NSC vs SMMT · P/E 18, rev $6.46B vs $11.46B cap
Norfolk Southern Corporation (NSC) versus Summit Therapeutics PLC (SMMT) — a side-by-side from cached financials, not a winner call.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
Summit Therapeutics PLC (SMMT) is a biotechnology company listed on US.
Latest reported NSC revenue for 2026-06-30 was $6.46B. Net income was $1.28B. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
SMMT does not have a complete income-statement cache yet.
NSC currently screens at market cap $60.10B and trailing P/E 18.2. SMMT currently screens at market cap $11.46B.
Not investment advice. Open the NSC and SMMT stock pages for the full models.
Not investment advice.